Skip to main content
. 2014 Nov 5;30(1):149–158. doi: 10.1093/humrep/deu288

Figure 3.

Figure 3

Effect of IAPs inhibitor (BV6) on cell proliferation of human eutopic (disease-free or uterine myoma) and ectopic ESCs. After BV6 treatment for 24 h, BrdU-ELISA was performed. Seven different samples in each group were used. Results were analyzed using one-way ANOVA followed by Fisher's protected least significant differences post hoc test. Bars that do not share a letter are significantly different (P < 0.05).